Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Sinew Pharma Inc. (6634.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-34.62
P/B ratioShare price divided by book value per share.
3.81
P/S ratioMarket value divided by annual revenue.
84029.93
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-23.22
EV / RevenueEnterprise value against annual revenue.
63115.02
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-2.89%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
78.72%
Operating marginRevenue left after operating costs.
-283142.55%
Net marginRevenue left after every cost, including tax and interest.
0.00%
Return on equityProfit as a percentage of shareholders’ equity.
-10.85%
Return on assetsProfit as a percentage of total assets.
-7.40%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
46.43
Quick ratioThe same, excluding inventory.
46.35
Debt to equityTotal borrowings against shareholders’ equity.
0.01
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-1.60
Book value per shareShareholders’ equity divided by shares outstanding.
$14.55
Shares outstandingShares currently issued.
71,288,930
Market capitalisationShare price times shares outstanding.
$3.95B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
57
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Sinew Pharma Inc. (6634.TWO) statistics — frequently asked questions
What is Sinew Pharma Inc.'s P/E ratio?
Sinew Pharma Inc. (6634.TWO) trades on a price-to-earnings ratio of -34.62. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Sinew Pharma Inc.'s return on equity?
Sinew Pharma Inc. (6634.TWO) reports a return on equity of -10.85%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Sinew Pharma Inc. carry?
Sinew Pharma Inc. (6634.TWO) has a debt-to-equity ratio of 0.01, which compares total borrowings with shareholders' equity.